APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chain Pharmacy Prescription Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chain Pharmacy Prescription Drugs Industry Growth and Trends Forecast to 2032

23 December 2025112 pages

Choose your research edition.

Industry ResearchChain Pharmacy Prescription Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Chain Pharmacy Prescription Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Chain Pharmacy Prescription Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chain Pharmacy Prescription Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Chain Pharmacy Prescription Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Chain Pharmacy Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chain Pharmacy Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chain Pharmacy Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chain Pharmacy Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Chain Pharmacy Prescription Drugs market include Yifeng Pharmacy Chain, Yixintang Pharmaceutical Group, Laobaixing Pharmacy Chain, Sinopharm Group, DaShenLin Pharmaceutical Group, Walgreens Boots Alliance, Walgreens, Superdrug and Rite Aid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chain Pharmacy Prescription Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chain Pharmacy Prescription Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chain Pharmacy Prescription Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chain Pharmacy Prescription Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Chain Pharmacy Prescription Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chain Pharmacy Prescription Drugs Market by Company

Yifeng Pharmacy Chain

Yixintang Pharmaceutical Group

Laobaixing Pharmacy Chain

Sinopharm Group

DaShenLin Pharmaceutical Group

Walgreens Boots Alliance

Walgreens

Superdrug

Rite Aid

Pharmacy2U

Health Mart

CVS Health

Celesio

Boots UK

Alphega Pharmacy

Chain Pharmacy Prescription Drugs Segment by Type

Tumor Treatment Drugs

Cardiovascular Drugs

Digestive System Drugs

Nervous System Drugs

Endocrine System Drugs

Immune Modulators

Anti-Infective Drugs

Respiratory Drugs

Others

Chain Pharmacy Prescription Drugs Segment by Application

Prophylaxis

Chronic Disease Management

Clinical Treatment

Scientific Research

Others

Chain Pharmacy Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chain Pharmacy Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chain Pharmacy Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chain Pharmacy Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Chain Pharmacy Prescription Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Chain Pharmacy Prescription Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Chain Pharmacy Prescription Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Chain Pharmacy Prescription Drugs Market Share by Region (2021-2026) Table 4. Global Chain Pharmacy Prescription Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Chain Pharmacy Prescription Drugs Market Share by Region (2027-2032) Table 6. Global Chain Pharmacy Prescription Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chain Pharmacy Prescription Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2026) Table 9. Global Chain Pharmacy Prescription Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Chain Pharmacy Prescription Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Chain Pharmacy Prescription Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Chain Pharmacy Prescription Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2026) Table 24. Global Chain Pharmacy Prescription Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Chain Pharmacy Prescription Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Chain Pharmacy Prescription Drugs Industry Trends Table 37. Chain Pharmacy Prescription Drugs Industry Drivers Table 38. Chain Pharmacy Prescription Drugs Industry Opportunities and Challenges Table 39. Chain Pharmacy Prescription Drugs Industry Restraints Table 40. Global Chain Pharmacy Prescription Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Chain Pharmacy Prescription Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Chain Pharmacy Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Chain Pharmacy Prescription Drugs Key Company Headquarters & Area Served Table 44. Global Chain Pharmacy Prescription Drugs Company, Product Type & Application Table 45. Global Chain Pharmacy Prescription Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Chain Pharmacy Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Yifeng Pharmacy Chain Company Information Table 49. Yifeng Pharmacy Chain Business Overview Table 50. Yifeng Pharmacy Chain Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Yifeng Pharmacy Chain Chain Pharmacy Prescription Drugs Product Portfolio Table 52. Yifeng Pharmacy Chain Recent Development Table 53. Yixintang Pharmaceutical Group Company Information Table 54. Yixintang Pharmaceutical Group Business Overview Table 55. Yixintang Pharmaceutical Group Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Yixintang Pharmaceutical Group Chain Pharmacy Prescription Drugs Product Portfolio Table 57. Yixintang Pharmaceutical Group Recent Development Table 58. Laobaixing Pharmacy Chain Company Information Table 59. Laobaixing Pharmacy Chain Business Overview Table 60. Laobaixing Pharmacy Chain Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Laobaixing Pharmacy Chain Chain Pharmacy Prescription Drugs Product Portfolio Table 62. Laobaixing Pharmacy Chain Recent Development Table 63. Sinopharm Group Company Information Table 64. Sinopharm Group Business Overview Table 65. Sinopharm Group Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sinopharm Group Chain Pharmacy Prescription Drugs Product Portfolio Table 67. Sinopharm Group Recent Development Table 68. DaShenLin Pharmaceutical Group Company Information Table 69. DaShenLin Pharmaceutical Group Business Overview Table 70. DaShenLin Pharmaceutical Group Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. DaShenLin Pharmaceutical Group Chain Pharmacy Prescription Drugs Product Portfolio Table 72. DaShenLin Pharmaceutical Group Recent Development Table 73. Walgreens Boots Alliance Company Information Table 74. Walgreens Boots Alliance Business Overview Table 75. Walgreens Boots Alliance Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Walgreens Boots Alliance Chain Pharmacy Prescription Drugs Product Portfolio Table 77. Walgreens Boots Alliance Recent Development Table 78. Walgreens Company Information Table 79. Walgreens Business Overview Table 80. Walgreens Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Walgreens Chain Pharmacy Prescription Drugs Product Portfolio Table 82. Walgreens Recent Development Table 83. Superdrug Company Information Table 84. Superdrug Business Overview Table 85. Superdrug Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Superdrug Chain Pharmacy Prescription Drugs Product Portfolio Table 87. Superdrug Recent Development Table 88. Rite Aid Company Information Table 89. Rite Aid Business Overview Table 90. Rite Aid Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Rite Aid Chain Pharmacy Prescription Drugs Product Portfolio Table 92. Rite Aid Recent Development Table 93. Pharmacy2U Company Information Table 94. Pharmacy2U Business Overview Table 95. Pharmacy2U Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pharmacy2U Chain Pharmacy Prescription Drugs Product Portfolio Table 97. Pharmacy2U Recent Development Table 98. Health Mart Company Information Table 99. Health Mart Business Overview Table 100. Health Mart Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Health Mart Chain Pharmacy Prescription Drugs Product Portfolio Table 102. Health Mart Recent Development Table 103. CVS Health Company Information Table 104. CVS Health Business Overview Table 105. CVS Health Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. CVS Health Chain Pharmacy Prescription Drugs Product Portfolio Table 107. CVS Health Recent Development Table 108. Celesio Company Information Table 109. Celesio Business Overview Table 110. Celesio Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Celesio Chain Pharmacy Prescription Drugs Product Portfolio Table 112. Celesio Recent Development Table 113. Boots UK Company Information Table 114. Boots UK Business Overview Table 115. Boots UK Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Boots UK Chain Pharmacy Prescription Drugs Product Portfolio Table 117. Boots UK Recent Development Table 118. Alphega Pharmacy Company Information Table 119. Alphega Pharmacy Business Overview Table 120. Alphega Pharmacy Chain Pharmacy Prescription Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Alphega Pharmacy Chain Pharmacy Prescription Drugs Product Portfolio Table 122. Alphega Pharmacy Recent Development Table 123. North America Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Chain Pharmacy Prescription Drugs Market Share by Country (2021-2026) Table 126. North America Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Chain Pharmacy Prescription Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Chain Pharmacy Prescription Drugs Market Share by Country (2021-2026) Table 131. Europe Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Chain Pharmacy Prescription Drugs Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Chain Pharmacy Prescription Drugs Market Share by Country (2021-2026) Table 136. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Chain Pharmacy Prescription Drugs Market Share Forecast by Country (2027-2032) Table 138. Latin America Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Chain Pharmacy Prescription Drugs Market Share by Country (2021-2026) Table 141. Latin America Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Chain Pharmacy Prescription Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Chain Pharmacy Prescription Drugs Market Share by Country (2021-2026) Table 146. Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Chain Pharmacy Prescription Drugs Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Chain Pharmacy Prescription Drugs Product Image Figure 3. Global Chain Pharmacy Prescription Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Chain Pharmacy Prescription Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Chain Pharmacy Prescription Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Chain Pharmacy Prescription Drugs Market Share by Region (2021-2032) Figure 7. North America Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tumor Treatment Drugs Image Figure 13. Global Tumor Treatment Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cardiovascular Drugs Image Figure 15. Global Cardiovascular Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Digestive System Drugs Image Figure 17. Global Digestive System Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Nervous System Drugs Image Figure 19. Global Nervous System Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Endocrine System Drugs Image Figure 21. Global Endocrine System Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Immune Modulators Image Figure 23. Global Immune Modulators Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Anti-Infective Drugs Image Figure 25. Global Anti-Infective Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Respiratory Drugs Image Figure 27. Global Respiratory Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Others Image Figure 29. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Global Chain Pharmacy Prescription Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 31. Global Chain Pharmacy Prescription Drugs Market Share by Type 2025 VS 2032 Figure 32. North America Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2032) Figure 33. Europe Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2032) Figure 34. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2032) Figure 35. Latin America Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2032) Figure 36. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Share by Type (2021-2032) Figure 37. Prophylaxis Image Figure 38. Global Prophylaxis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Chronic Disease Management Image Figure 40. Global Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Clinical Treatment Image Figure 42. Global Clinical Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Scientific Research Image Figure 44. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Others Image Figure 46. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Global Chain Pharmacy Prescription Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Chain Pharmacy Prescription Drugs Market Share by Application 2025 VS 2032 Figure 49. North America Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2032) Figure 50. Europe Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2032) Figure 51. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2032) Figure 52. Latin America Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2032) Figure 53. Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Share by Application (2021-2032) Figure 54. Global Top 5 and 10 Chain Pharmacy Prescription Drugs Players Market Share by Revenue in 2025 Figure 55. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 56. North America Chain Pharmacy Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. North America Chain Pharmacy Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. North America Chain Pharmacy Prescription Drugs Market Share by Country (2021-2032) Figure 59. Europe Chain Pharmacy Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Chain Pharmacy Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Chain Pharmacy Prescription Drugs Market Share by Country (2021-2032) Figure 62. Asia-Pacific Chain Pharmacy Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Asia-Pacific Chain Pharmacy Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Chain Pharmacy Prescription Drugs Market Share by Country (2021-2032) Figure 65. Latin America Chain Pharmacy Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Chain Pharmacy Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Chain Pharmacy Prescription Drugs Market Share by Country (2021-2032) Figure 68. Middle East & Africa Chain Pharmacy Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 69. Middle East & Africa Chain Pharmacy Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 70. Middle East & Africa Chain Pharmacy Prescription Drugs Market Share by Country (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Treatment Drugs
  • Cardiovascular Drugs
  • Digestive System Drugs
  • Nervous System Drugs
  • Endocrine System Drugs
  • Immune Modulators
  • Anti-Infective Drugs
  • Respiratory Drugs
  • Others
Applications
  • Prophylaxis
  • Chronic Disease Management
  • Clinical Treatment
  • Scientific Research
  • Others
Companies covered
  • Yifeng Pharmacy Chain
  • Yixintang Pharmaceutical Group
  • Laobaixing Pharmacy Chain
  • Sinopharm Group
  • DaShenLin Pharmaceutical Group
  • Walgreens Boots Alliance
  • Walgreens
  • Superdrug
  • Rite Aid
  • Pharmacy2U
  • Health Mart
  • CVS Health
  • Celesio
  • Boots UK
  • Alphega Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Chain Pharmacy Prescription Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Chain Pharmacy Prescription Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Chain Pharmacy Prescription Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Chain Pharmacy Prescription Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Chain Pharmacy Prescription Drugs Market Size (2021-2032)
  8. 1.5.1 North America Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Growth Rate (2021-2032)
2 Chain Pharmacy Prescription Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tumor Treatment Drugs
  3. 2.1.2 Cardiovascular Drugs
  4. 2.1.3 Digestive System Drugs
  5. 2.1.4 Nervous System Drugs
  6. 2.1.5 Endocrine System Drugs
  7. 2.1.6 Immune Modulators
  8. 2.1.7 Anti-Infective Drugs
  9. 2.1.8 Respiratory Drugs
  10. 2.1.9 Others
  11. 2.2 Global Chain Pharmacy Prescription Drugs Market Size by Type
  12. 2.2.1 Global Chain Pharmacy Prescription Drugs Market Size Overview by Type (2021-2032)
  13. 2.2.2 Global Chain Pharmacy Prescription Drugs Historic Market Size Review by Type (2021-2026)
  14. 2.2.3 Global Chain Pharmacy Prescription Drugs Market Size Forecasted by Type (2027-2032)
  15. 2.3 Global Chain Pharmacy Prescription Drugs Market Size by Regions
  16. 2.3.1 North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026)
  17. 2.3.2 Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026)
  18. 2.3.3 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026)
  19. 2.3.4 South America Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026)
  20. 2.3.5 Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Type (2021-2026)
3 Chain Pharmacy Prescription Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Prophylaxis
  3. 3.1.2 Chronic Disease Management
  4. 3.1.3 Clinical Treatment
  5. 3.1.4 Scientific Research
  6. 3.1.5 Others
  7. 3.2 Global Chain Pharmacy Prescription Drugs Market Size by Application
  8. 3.2.1 Global Chain Pharmacy Prescription Drugs Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Chain Pharmacy Prescription Drugs Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Chain Pharmacy Prescription Drugs Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Chain Pharmacy Prescription Drugs Market Size by Regions
  12. 3.3.1 North America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Chain Pharmacy Prescription Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Chain Pharmacy Prescription Drugs Industry Trends
  2. 4.2 Chain Pharmacy Prescription Drugs Industry Drivers
  3. 4.3 Chain Pharmacy Prescription Drugs Industry Opportunities and Challenges
  4. 4.4 Chain Pharmacy Prescription Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Chain Pharmacy Prescription Drugs Revenue (2021-2026)
  2. 5.2 Global Chain Pharmacy Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Chain Pharmacy Prescription Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Chain Pharmacy Prescription Drugs Company, Product Type & Application
  5. 5.5 Global Chain Pharmacy Prescription Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Chain Pharmacy Prescription Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Chain Pharmacy Prescription Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Chain Pharmacy Prescription Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Yifeng Pharmacy Chain
  2. 6.1.1 Yifeng Pharmacy Chain Company Information
  3. 6.1.2 Yifeng Pharmacy Chain Business Overview
  4. 6.1.3 Yifeng Pharmacy Chain Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Yifeng Pharmacy Chain Chain Pharmacy Prescription Drugs Product Portfolio
  6. 6.1.5 Yifeng Pharmacy Chain Recent Developments
  7. 6.2 Yixintang Pharmaceutical Group
  8. 6.2.1 Yixintang Pharmaceutical Group Company Information
  9. 6.2.2 Yixintang Pharmaceutical Group Business Overview
  10. 6.2.3 Yixintang Pharmaceutical Group Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Yixintang Pharmaceutical Group Chain Pharmacy Prescription Drugs Product Portfolio
  12. 6.2.5 Yixintang Pharmaceutical Group Recent Developments
  13. 6.3 Laobaixing Pharmacy Chain
  14. 6.3.1 Laobaixing Pharmacy Chain Company Information
  15. 6.3.2 Laobaixing Pharmacy Chain Business Overview
  16. 6.3.3 Laobaixing Pharmacy Chain Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Laobaixing Pharmacy Chain Chain Pharmacy Prescription Drugs Product Portfolio
  18. 6.3.5 Laobaixing Pharmacy Chain Recent Developments
  19. 6.4 Sinopharm Group
  20. 6.4.1 Sinopharm Group Company Information
  21. 6.4.2 Sinopharm Group Business Overview
  22. 6.4.3 Sinopharm Group Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sinopharm Group Chain Pharmacy Prescription Drugs Product Portfolio
  24. 6.4.5 Sinopharm Group Recent Developments
  25. 6.5 DaShenLin Pharmaceutical Group
  26. 6.5.1 DaShenLin Pharmaceutical Group Company Information
  27. 6.5.2 DaShenLin Pharmaceutical Group Business Overview
  28. 6.5.3 DaShenLin Pharmaceutical Group Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 DaShenLin Pharmaceutical Group Chain Pharmacy Prescription Drugs Product Portfolio
  30. 6.5.5 DaShenLin Pharmaceutical Group Recent Developments
  31. 6.6 Walgreens Boots Alliance
  32. 6.6.1 Walgreens Boots Alliance Company Information
  33. 6.6.2 Walgreens Boots Alliance Business Overview
  34. 6.6.3 Walgreens Boots Alliance Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Walgreens Boots Alliance Chain Pharmacy Prescription Drugs Product Portfolio
  36. 6.6.5 Walgreens Boots Alliance Recent Developments
  37. 6.7 Walgreens
  38. 6.7.1 Walgreens Company Information
  39. 6.7.2 Walgreens Business Overview
  40. 6.7.3 Walgreens Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Walgreens Chain Pharmacy Prescription Drugs Product Portfolio
  42. 6.7.5 Walgreens Recent Developments
  43. 6.8 Superdrug
  44. 6.8.1 Superdrug Company Information
  45. 6.8.2 Superdrug Business Overview
  46. 6.8.3 Superdrug Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Superdrug Chain Pharmacy Prescription Drugs Product Portfolio
  48. 6.8.5 Superdrug Recent Developments
  49. 6.9 Rite Aid
  50. 6.9.1 Rite Aid Company Information
  51. 6.9.2 Rite Aid Business Overview
  52. 6.9.3 Rite Aid Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Rite Aid Chain Pharmacy Prescription Drugs Product Portfolio
  54. 6.9.5 Rite Aid Recent Developments
  55. 6.10 Pharmacy2U
  56. 6.10.1 Pharmacy2U Company Information
  57. 6.10.2 Pharmacy2U Business Overview
  58. 6.10.3 Pharmacy2U Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pharmacy2U Chain Pharmacy Prescription Drugs Product Portfolio
  60. 6.10.5 Pharmacy2U Recent Developments
  61. 6.11 Health Mart
  62. 6.11.1 Health Mart Company Information
  63. 6.11.2 Health Mart Business Overview
  64. 6.11.3 Health Mart Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Health Mart Chain Pharmacy Prescription Drugs Product Portfolio
  66. 6.11.5 Health Mart Recent Developments
  67. 6.12 CVS Health
  68. 6.12.1 CVS Health Company Information
  69. 6.12.2 CVS Health Business Overview
  70. 6.12.3 CVS Health Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 CVS Health Chain Pharmacy Prescription Drugs Product Portfolio
  72. 6.12.5 CVS Health Recent Developments
  73. 6.13 Celesio
  74. 6.13.1 Celesio Company Information
  75. 6.13.2 Celesio Business Overview
  76. 6.13.3 Celesio Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Celesio Chain Pharmacy Prescription Drugs Product Portfolio
  78. 6.13.5 Celesio Recent Developments
  79. 6.14 Boots UK
  80. 6.14.1 Boots UK Company Information
  81. 6.14.2 Boots UK Business Overview
  82. 6.14.3 Boots UK Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Boots UK Chain Pharmacy Prescription Drugs Product Portfolio
  84. 6.14.5 Boots UK Recent Developments
  85. 6.15 Alphega Pharmacy
  86. 6.15.1 Alphega Pharmacy Company Information
  87. 6.15.2 Alphega Pharmacy Business Overview
  88. 6.15.3 Alphega Pharmacy Chain Pharmacy Prescription Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Alphega Pharmacy Chain Pharmacy Prescription Drugs Product Portfolio
  90. 6.15.5 Alphega Pharmacy Recent Developments
7 North America
  1. 7.1 North America Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Chain Pharmacy Prescription Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Chain Pharmacy Prescription Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst